DOCSLIB.ORG

Evaluation of Antibiotic Consumption at Rakovica Community Health Center

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Evaluation of Antibiotic Consumption at Rakovica Community Health Center ORIGINAL SCIENTIFIC PAPER ORIGINALNI NAUČNI RAD ORIGINAL SCIENTIFIC PAPER EVALUATION OF ANTIBIOTIC CONSUMPTION AT RAKOVICA COMMUNITY HEALTH CENTER FROM 2011 TO 2015 Marijana Tomic Smiljanic1, Vesela Radonjic2, Dusan Djuric3 1 Community Health Center in Rakovica, Belgrade, Serbia 2 Medicines and Medical Devices Agency of Serbia, Belgrade; University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pharmacy 3 University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pharmacy EVALUACIJA POTROŠNJE ANTIBIOTIKA U DOMU ZDRAVLJA RAKOVICA U PERIODU 2011_2015. GODINA Marijana Tomić Smiljanić1, Vesela Radonjić2, Dušan Đurić3 1 Dom zrdavlja Rakovica, Beograd, Srbija 2 Agencija za lekove i medicinska sredstva Srbije, Beograd, Univerzitet u Kragujevcu, Srbija, Fakultet medicinskih nauka, Odsek za farmaciju 3 Univerzitet u Kragujevcu, Srbija, Fakultet medicinskih nauka, Odsek za farmaciju Received / Primljen: 08.06.2016. Accepted / Prihvaćen: 12.07.2016. ABSTRACT SAŽETAK Antibacterial drugs are among the major discoveries of the Antibakterijski lekovi su među najvećim otkrićima 20. 20th century because they signifi cantly reduced the rate of mor- veka, jer su znatno smanjili stopu obolevanja i smrtnosti bidity and mortality as well as the risk of infections related to od infektivnih bolesti i rizik od infekcije kod invazivnih invasive medical procedures. Indiscriminate and wrongful use medicinskih procedura. Neodgovorna i pogrešna upotre- of these powerful life-saving drugs has led to the development ba ovih moćnih lekova koji spasavaju život dovela je do of resistance of numerous microorganisms, resulting in an in- razvoja rezistencije mnogih mikroorganizama na njih, a crease in the number of hospital-acquired infections with a fatal rezultat toga je i porast bolničkih infekcija sa smrtnim outcome. Th us, it is very important to establish the volume of ishodom. Veoma je važno utvrđivanje obima potrošnje antibiotic consumption and surveillance of antimicrobial resis- antibiotika i nadzora nad antimikrobnom rezistencijom, tance in order to rationalize the use of this important group of radi racionalizacije upotrebe ove važne grupe lekova. Pri- medications. Th e usage unique ATC/DDD methodology results menjena je jedinstvena ATC/DDD metodologija, rezulta- expressed as Defi ned Daily Doses (DDD)/1000 inhabitants per ti su izraženi kao broj upotrebljenih definisanih dnevnih day (DID) has enabled the comparison of antibiotic consump- doza (DDD)/1000 stanovnika /dan (DID) omogućila je tion in Serbia to that in other countries for a better understand- poređenje potrošnje antibiotika u Srbiji sa drugim zemlja- ing of our results. Th e community health center in Rakovica pro- ma i bolje razumevanje naših rezultata. U Domu zdravlja vides treatment for approximately 70,820 patients. Th e volume Rakovica leči se oko 70820 pacijenata. Izračunat je obim of overall antibiotic consumption has been calculated as well as ukupne potrošnje antibiotika kao i ucešće pojedinih anti- the use of certain antibiotics in the total consumption and com- biotika u ukupnoj potrošnji i poređenje sa vodičima dobre parison of the guides for good clinical practice. Th e most pre- kliničke prakse. scribed antibiotics were antibiotics for diseases of the respiratory system. Th e most prescribed groups of antibiotics were penicillin Najviše su propisivani antibiotici za bolesti respiratornog drugs, which are an optimal choice as per the guides for good sistema. Najpropisivanija grupa antibiotika su penicilini, što clinical practice. Amoxicillin are the most frequently prescribed je u skladu sa vodičima dobre kliničke prakse. Zapažen je individual antibiotic. A yearly increase in prescribing penicillin porast propisivanja penicilina iz godine u godinu sa domi- was observed. A rise in consumption of all generations of quino- nacijom amoksicilina. Zapaža se i porast propisivanja hino- lones was observed, particularly for levofl oxacine, which is not lona, posebno levofl oksacina, što nije u skladu sa preporuka- in accordance with the recommendations. ma vodiča dobre kliničke prakse. Keywords: Rational use of antibiotics, DID, antibiotic Ključne reči: racionalna upotreba antibiotika, DID, po- consumption trošnja antibiotika UDK: 615.33497.11”2011/2015” / SER J EXP CLIN RES 2017; 18 3: 245250 DOI: 10.1515/SJECR20160054 Corresponding author: Vesela Radonjic, University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pharmacy; E-mail: [email protected] 245 INTRODUCTION as profitable as the ones that treat chronic illnesses. Indis- criminate use of antibiotics has led to the emergence of In 1985, the World Health Organization (WHO) de- multidrug resistant microorganisms–MRSA, VRSA, VRE, fined the rational use of drugs as a process in which the etc. The problem of the increasing resistance of microor- patients obtain medications that suit their needs, in doses ganisms to antibiotics has become a global health issue (6). suitable for them, within an appropriate length of time and The choice of therapy should rely either on the culture at the lowest cost for them and the society they live in (1). and identification of bacterial pathogens and the results Currently, the irrational use of medications, with all of of the sensitivity test (directed therapy) or on the familiar its negative implications, represents a continuing process common pathogens in the given state and their common that takes on increasing proportions and is thus consid- forms of resistance (empirical therapy). ered to be one of the biggest global public health issues (2). The basic principles of the rational use of antibiotics Of all the drugs, antibiotics have played the greatest are as follows: role in indiscriminate drug prescriptions. The discovery • Based on the localization of the infection, the causative and use of antimicrobial drugs for the treatment of infec- agent that is in question can be assumed. tions constitutes the biggest success of modern medicine. • An empirical antibiotic choice during the initial patient Approximately 80 % of all antibiotics prescribed in health contact should be made. care institutions are being prescribed within primary • Sampling for microbiological survey should be conduct- health care settings and most frequently for respiratory ed prior to administering antibiotics. tract infections. A non-clinical factor, such as the pressure • Within 48-72 hours, the effectiveness of antibiotics that is exerted on doctors by the patients, also has a large should be reconsidered, and in view of microbiological impact on antibiotic prescriptions, but the doctors them- findings, the choice of whether to continue or change selves prescribe antibiotics quite often and unjustifiably the application of antibiotics should be decided. (3). A study has been performed involving patients with • Apply the antibiotic for a sufficient length of time to symptoms of cough where antibiotics are quite frequently treat the infection in question. administered, showing that there is no difference in the de- One of the ways to achieve this goal is to evaluate and gree of recovery between the patients treated with antibi- correct the antibiotic prescribing habits in all health care otics and the ones who did not receive them (4). institutions, principally in the primary health care system The introduction of a mandatory continuing medical such as community health centers (7). This study has ex- education (CME) requirement for health workers in the amined the protocols on antibiotic prescribing at Rakovica Republic of Serbia regulated by the Law on Health Care Community Health Center, Belgrade. and Rules will probably have an impact on solving this problem. Apart from other public health measures that have led GOAL to the extension of life expectancy, the use of antibiotics is certainly of great importance. However, the success in The main goal of this study is to provide insight into the treatment of infections is compromised by their irrational volume of consumption of antibiotics and the participa- use, which has led to bacterial resistance of these medica- tion of certain antibiotics in their overall consumption at tions. Irrational use is defined as microbiologically ineffi- Rakovica Community Health Center, as well as to compare cient antimicrobial therapy that can have adverse effects the volume to the national guidelines effective in Serbia on the outcome of treatment. The irrational use of anti- and the ESAC (European Surveillance of Antimicrobial microbial drugs is important not only from the clinical as- Consumption) recommendations. pect, i.e. because of the outcome of the patient treatment, but also from the public health aspect since it represents one of the main factors for the emergence of resistance of METHODOLOGY infectious agents (5). With an aim at preventing resistance, antimicrobial The monitoring of antibiotic use refers to a five-year drugs should be administered rationally, which according to period (2011 -2015) involving patients over 18 years of age current concepts means that their usage should not be em- at the adult health care service at Rakovica Community pirical but rather targeted and based on diagnostic evidence. Health Center. The community health center in Rakov- Over the last 30 years, the development of new antibi- ica provides treatment for approximately 70,820 patients otics has considerably decreased, while the options to treat (30,016 male and 40,657 female). infections caused by resistant agents, which are increas-
Load more

Recommended publications
  • 1057-1064, 1984 the Effect of Pipemidic Acid on The
    Microbiol. Immunol. Vol. 28 (9), 1057-1064, 1984 The Effect of Pipemidic Acid on the Growth of a Stable L-Form of •ôNH•ôStaphylococcus aureus•ôNS•ô Kunihiko YABU,*,1 Hiromi ToMizu,1 and Yayoi KANDA2 1 Department of Biology, Hokuriku University School of Pharmacy, Kanazawa-machi, Kanazawa, Ishikawa ,920-11, and 2Department of Microbiology, Teikyo University School of Medicine, Kaga 2-chome, Ilabashi-ku, Tokyo 173 (Accepted for publication, June 12, 1984) Bacterial L-forms usually display spherical forms in an osmotically protective medium and seem to lack the typical binary fission process of cellular division ob servedin most bacteria (7). Although various modes of replication, such as budding binary fission, and release of elementary bodies from large bodies have been observed by light and electron microscopy (2, 5, 16), little is known about the processes involved in replication of L-forms. In the course of an experiment designed to test the effect of DNA synthesis inhibitors on the growth of a stable L-form of •ôNH•ôStaphylococcus•ôNS•ôaureus which grows in liquid medium, it was found that pipemidic acid, a synthetic antibacterial agent structurally related to nalidixic acid (13), induced a marked morphological altera tionat growth inhibitory concentrations. This study was initiated in an attempt to clarify the mechanism of replication of stable L-forms by analyzing the mor phologicalalteration caused by pipemidic acid. The stable L-form used was isolated as follows. S. •ôNH•ôaureus•ôNS•ôFDA 209P was grown in 10ml of Brain Heart Infusion broth (Difco) at 37C. The culture grown at 5•~105 colony-forming units (CFU) per ml was washed with saline by filtration and suspended in saline containing 100ƒÊg of N-methyl-N'-nitro-N-nitrosoguanidine per nil.
    [Show full text]
  • Clinically Isolated Chlamydia Trachomatis Strains
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUIY 1988, p. 1080-1081 Vol. 32, No. 7 0066-4804/88/071080-02$02.00/0 Copyright © 1988, American Society for Microbiology In Vitro Activities of T-3262, NY-198, Fleroxacin (AM-833; RO 23-6240), and Other New Quinolone Agents against Clinically Isolated Chlamydia trachomatis Strains HIROSHI MAEDA,* AKIRA FUJII, KATSUHISA NAKATA, SOICHI ARAKAWA, AND SADAO KAMIDONO Department of Urology, School of Medicine, Kobe University, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe-city, Japan Received 9 December 1987/Accepted 29 March 1988 The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10 strains of clinically isolated Chiamydia trachomatis were assessed and compared with those of other quinolones and minocycline. T-3262 (MIC for 90% of isolates tested, 0.1 ,ug/ml) was the most active of the quinolones. The NY-198 and fleroxacin MICs for 90% of isolates were 3.13 and 62.5 ,ug/ml, respectively. Recently, it has become well known that Chlamydia 1-ml sample of suspension was seeded into flat-bottomed trachomatis is an important human pathogen. It is respon- tubes with glass cover slips and incubated at 37°C in 5% CO2 sible not only for trachoma but also for sexually transmitted for 24 h. The monolayer was inoculated with 103 inclusion- infections, including lymphogranuloma venereum. In forming units of C. trachomatis. The tubes were centrifuged women, it causes cervicitis, endometritis, and salpingitis at 2,000 x g at 25°C for 45 min and left undisturbed at room asymptomatically (19), while in men it causes nongono- temperature for 2 h.
    [Show full text]
  • Antibiotic Resistance in the European Union Associated with Therapeutic Use of Veterinary Medicines
    The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/CVMP/342/99-Final Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products 14 July 1999 Public 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Switchboard: (+44-171) 418 8400 Fax: (+44-171) 418 8447 E_Mail: [email protected] http://www.eudra.org/emea.html ãEMEA 1999 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged TABLE OF CONTENTS Page 1. INTRODUCTION 1 1.1 DEFINITION OF ANTIBIOTICS 1 1.1.1 Natural antibiotics 1 1.1.2 Semi-synthetic antibiotics 1 1.1.3 Synthetic antibiotics 1 1.1.4 Mechanisms of Action 1 1.2 BACKGROUND AND HISTORY 3 1.2.1 Recent developments 3 1.2.2 Authorisation of Antibiotics in the EU 4 1.3 ANTIBIOTIC RESISTANCE 6 1.3.1 Microbiological resistance 6 1.3.2 Clinical resistance 6 1.3.3 Resistance distribution in bacterial populations 6 1.4 GENETICS OF RESISTANCE 7 1.4.1 Chromosomal resistance 8 1.4.2 Transferable resistance 8 1.4.2.1 Plasmids 8 1.4.2.2 Transposons 9 1.4.2.3 Integrons and gene cassettes 9 1.4.3 Mechanisms for inter-bacterial transfer of resistance 10 1.5 METHODS OF DETERMINATION OF RESISTANCE 11 1.5.1 Agar/Broth Dilution Methods 11 1.5.2 Interpretative criteria (breakpoints) 11 1.5.3 Agar Diffusion Method 11 1.5.4 Other Tests 12 1.5.5 Molecular techniques 12 1.6 MULTIPLE-DRUG RESISTANCE
    [Show full text]
  • Paper I and II)
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1335 Constraints on up-regulation of drug efflux in the evolution of ciprofloxacin resistance LISA PRASKI ALZRIGAT ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-554-9923-5 UPPSALA urn:nbn:se:uu:diva-320580 2017 Dissertation presented at Uppsala University to be publicly examined in B22, BMC, Husargatan 3, Uppsala, Friday, 9 June 2017 at 09:00 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: Professor Fernando Baquero (Departamento de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain). Abstract Praski Alzrigat, L. 2017. Constraints on up-regulation of drug efflux in the evolution of ciprofloxacin resistance. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1335. 48 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-9923-5. The crucial role of antibiotics in modern medicine, in curing infections and enabling advanced medical procedures, is being threatened by the increasing frequency of resistant bacteria. Better understanding of the forces selecting resistance mutations could help develop strategies to optimize the use of antibiotics and slow the spread of resistance. Resistance to ciprofloxacin, a clinically important antibiotic, almost always involves target mutations in DNA gyrase and Topoisomerase IV. Because ciprofloxacin is a substrate of the AcrAB-TolC efflux pump, mutations causing pump up-regulation are also common. Studying the role of efflux pump-regulatory mutations in the development of ciprofloxacin resistance, we found a strong bias against gene-inactivating mutations in marR and acrR in clinical isolates.
    [Show full text]
  • Allergy to Quinolones: Low Cross-Reactivity to Levofloxacin
    T Lobera, et al ORIGINAL ARTICLE Allergy to Quinolones: Low Cross-reactivity to Levofl oxacin T Lobera,1 MT Audícana,2 E Alarcón,1 N Longo,2 B Navarro,1 D Muñoz2 1Department of Allergy, Hospital San Pedro/San Millán, Logroño, Spain 2Department of Allergy, Hospital Santiago Apóstol, Vitoria, Spain ■ Abstract Background: Immediate-type hypersensitivity reactions to quinolones are rare. Some reports describe the presence of cross-reactivity among different members of the group, although no predictive pattern has been established. No previous studies confi rm or rule out cross-reactivity between levofl oxacin and other quinolones. Therefore, a joint study was designed between 2 allergy departments to assess cross-reactivity between levofl oxacin and other quinolones. Material and Methods: We studied 12 patients who had experienced an immediate-type reaction (4 anaphylaxis and 8 urticaria/angioedema) after oral administration of quinolones. The culprit drugs were as follows: ciprofl oxacin (5), levofl oxacin (4), levofl oxacin plus moxifl oxacin (1), moxifl oxacin (1), and norfl oxacin (1). Allergy was confi rmed by skin tests and controlled oral challenge tests with different quinolones. The basophil activation test (BAT) was applied in 6 patients. Results: The skin tests were positive in 5 patients with levofl oxacin (2), moxifl oxacin (2), and ofl oxacin (2). BAT was negative in all patients (6/6). Most of the ciprofl oxacin-reactive patients (4/5) tolerated levofl oxacin. Similarly, 3 of 4 levofl oxacin-reactive patients tolerated ciprofl oxacin. Patients who reacted to moxifl oxacin and norfl oxacin tolerated ciprofl oxacin and levofl oxacin. Conclusions: Our results suggest that skin testing and BAT do not help to identify the culprit drug or predict cross-reactivity.
    [Show full text]
  • Metal Complexes of Quinolone Antibiotics and Their Applications: an Update
    Molecules 2013, 18, 11153-11197; doi:10.3390/molecules180911153 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Metal Complexes of Quinolone Antibiotics and Their Applications: An Update Valentina Uivarosi Department of General and Inorganic Chemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia St, Bucharest 020956, Romania; E-Mail: [email protected]; Tel.: +4-021-318-0742; Fax: +4-021-318-0750 Received: 8 August 2013; in revised form: 2 September 2013 / Accepted: 2 September 2013 / Published: 11 September 2013 Abstract: Quinolones are synthetic broad-spectrum antibiotics with good oral absorption and excellent bioavailability. Due to the chemical functions found on their nucleus (a carboxylic acid function at the 3-position, and in most cases a basic piperazinyl ring (or another N-heterocycle) at the 7-position, and a carbonyl oxygen atom at the 4-position) quinolones bind metal ions forming complexes in which they can act as bidentate, as unidentate and as bridging ligand, respectively. In the polymeric complexes in solid state, multiple modes of coordination are simultaneously possible. In strongly acidic conditions, quinolone molecules possessing a basic side nucleus are protonated and appear as cations in the ionic complexes. Interaction with metal ions has some important consequences for the solubility, pharmacokinetics and bioavailability of quinolones, and is also involved in the mechanism of action of these bactericidal agents. Many metal complexes with equal or enhanced antimicrobial activity compared to the parent quinolones were obtained. New strategies in the design of metal complexes of quinolones have led to compounds with anticancer activity.
    [Show full text]
  • WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
    WHO Report on Surveillance of Antibiotic Consumption 2016-2018 Early implementation WHO Report on Surveillance of Antibiotic Consumption 2016 - 2018 Early implementation WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • The Grohe Method and Quinolone Antibiotics
    The Grohe method and quinolone antibiotics Antibiotics are medicines that are used to treat bacterial for modern fluoroquinolones. The Grohe process and the infections. They contain active ingredients belonging to var- synthesis of ciprofloxacin sparked Bayer AG’s extensive ious substance classes, with modern fluoroquinolones one research on fluoroquinolones and the global competition of the most important and an indispensable part of both that produced additional potent antibiotics. human and veterinary medicine. It is largely thanks to Klaus Grohe – the “father of Bayer quinolones” – that this entirely In chemical terms, the antibiotics referred to for simplicity synthetic class of antibiotics now plays such a vital role for as quinolones are derived from 1,4-dihydro-4-oxo-3-quin- medical practitioners. From 1965 to 1997, Grohe worked oline carboxylic acid (1) substituted in position 1. as a chemist, carrying out basic research at Bayer AG’s Fluoroquinolones possess a fluorine atom in position 6. In main research laboratory (WHL) in Leverkusen. During this addition, ciprofloxacin (2) has a cyclopropyl group in posi- period, in 1975, he developed the Grohe process – a new tion 1 and also a piperazine group in position 7 (Figure A). multi-stage synthesis method for quinolones. It was this This substituent pattern plays a key role in its excellent achievement that first enabled him to synthesize active an- antibacterial efficacy. tibacterial substances such as ciprofloxacin – the prototype O 5 O 4 3 6 COOH F COOH 7 2 N N N 8 1 H N R (1) (2) Figure A: Basic structure of quinolone (1) (R = various substituents) and ciprofloxacin (2) Quinolones owe their antibacterial efficacy to their inhibition This unique mode of action also makes fluoroquinolones of essential bacterial enzymes – DNA gyrase (topoisomer- highly effective against a large number of pathogenic ase II) and topoisomerase IV.
    [Show full text]
  • Simultaneous Determination of the Residues of Fourteen Quinolones
    Vol. 30, 2012, No. 1: 74–82 Czech J. Food Sci. Simultaneous Determination of the Residues of Fourteen Quinolones and Fluoroquinolones in Fish Samples using Liquid Chromatography with Photometric and Fluorescence Detection Florentina CAÑADA-CAÑADA, Anunciacion ESPINOSA-MAnsILLA, Ana JIMÉneZ GIRÓN and Arsenio MUÑOZ DE LA PeÑA Department of Analytical Chemistry, University of Extremadura, Badajoz, Spain Abstract Cañada-Cañada F., Espinosa-Mansilla A., Jiménez Girón A., Muñoz de la Peña A. (2012): Simul- taneous determination of the residues of fourteen quinolones and fluoroquinolones in fish samples using liquid chromatography with photometric and fluorescence detection. Czech J. Food Sci., 30: 74–82. A chromatographic method is described for assaying fourteen quinolones and fluoroquinolones (pipemidic acid, marbofloxacin, norfloxacin, ciprofloxacin, danofloxacin, lomefloxacin, enrofloxacin, sarafloxacin, difloxacin, oxolinic acid, nalidixic acid, flumequine, and pyromidic acid) in fish samples. The samples were extracted with m-phosphoric acid/acetonitrile mixture (75:25, v/v), purified, and preconcentrated on ENV + Isolute cartridges. The determina- tion was achieved by liquid chromatography using C18 analytical column. A mobile phase composed of mixtures of methanol-acetonitrile-10mM citrate buffer at pH 4.5, delivered under optimum gradient program, at a flow rate of 1.5 ml/min, allows accomplishing the chromatographic separation in 26 minutes. For the detection were used serial UV-visible diode-array at 280 nm and 254 nm and fluorescence detection at excitation wavelength/emission wavelength: 280/450, 280/495, and 280/405 nm. The detection and quantification limits were between 0.2–9.5 and 0.7–32 µg/kg, respectively. The procedure was applied to the analysis of spiked salmon samples at two different concentration levels (50 µg/k and 100 µg/kg).
    [Show full text]
  • Mechanism of Action of Pefloxacin on Surface Morphology, DNA Gyrase Activity and Dehydrogenase Enzymes of Klebsiella Aerogenes
    African Journal of Biotechnology Vol. 10(72), pp. 16330-16336, 16 November, 2011 Available online at http://www.academicjournals.org/AJB DOI: 10.5897/AJB11.2071 ISSN 1684–5315 © 2011 Academic Journals Full Length Research Paper Mechanism of action of pefloxacin on surface morphology, DNA gyrase activity and dehydrogenase enzymes of Klebsiella aerogenes Neeta N. Surve and Uttamkumar S. Bagde Department of Life Sciences, Applied Microbiology Laboratory, University of Mumbai, Vidyanagari, Santacruz (E), Mumbai 400098, India. Accepted 30 September, 2011 The aim of the present study was to investigate susceptibility of Klebsiella aerogenes towards pefloxacin. The MIC determined by broth dilution method and Hi-Comb method was 0.1 µg/ml. Morphological alterations on the cell surface of the K. aerogenes was shown by scanning electron microscopy (SEM) after the treatment with pefloxacin. It was observed that the site of pefloxacin action was intracellular and it caused surface alterations. The present investigation also showed the effect of Quinolone pefloxacin on DNA gyrase activity of K. aerogenes. DNA gyrase was purified by affinity chromatography and inhibition of pefloxacin on supercoiling activity of DNA gyrase was studied. Emphasis was also given on the inhibition effect of pefloxacin on dehydrogenase activity of K. aerogenes. Key words: Pefloxacin, Klebsiella aerogenes, scanning electron microscopy (SEM), deoxyribonucleic acid (DNA) gyrase, dehydrogenases, Hi-Comb method, minimum inhibitory concentration (MIC). INTRODUCTION Klebsiella spp. is opportunistic pathogen, which primarily broad spectrum activity with oral efficacy. These agents attack immunocompromised individuals who are have been shown to be specific inhibitors of the A subunit hospitalized and suffer from severe underlying diseases of the bacterial topoisomerase deoxyribonucleic acid such as diabetes mellitus or chronic pulmonary obstruc- (DNA) gyrase, the Gyr B protein being inhibited by tion.
    [Show full text]
  • Trends in Antibiotic Utilization in Eight Latin American Countries, 1997–2007
    Investigación original / Original research Trends in antibiotic utilization in eight Latin American countries, 1997–2007 Veronika J. Wirtz,1 Anahí Dreser,1 and Ralph Gonzales 2 Suggested citation Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American Countries, 1997–2007. Rev Panam Salud Publica. 2010;27(3):219–25. ABSTRACT Objective. To describe the trends in antibiotic utilization in eight Latin American countries between 1997–2007. Methods. We analyzed retail sales data of oral and injectable antibiotics (World Health Or- ganization (WHO) Anatomic Therapeutic Chemical (ATC) code J01) between 1997 and 2007 for Argentina, Brazil, Chile, Colombia, Mexico, Peru, Uruguay, and Venezuela. Antibiotics were aggregated and utilization was calculated for all antibiotics (J01); for macrolides, lin- cosamindes, and streptogramins (J01 F); and for quinolones (J01 M). The kilogram sales of each antibiotic were converted into defined daily dose per 1 000 inhabitants per day (DID) ac- cording to the WHO ATC classification system. We calculated the absolute change in DID and relative change expressed in percent of DID variation, using 1997 as a reference. Results. Total antibiotic utilization has increased in Peru, Venezuela, Uruguay, and Brazil, with the largest relative increases observed in Peru (5.58 DID, +70.6%) and Venezuela (4.81 DID, +43.0%). For Mexico (–2.43 DID; –15.5%) and Colombia (–4.10; –33.7%), utilization decreased. Argentina and Chile showed major reductions in antibiotic utilization during the middle of this period. In all countries, quinolone use increased, particularly sharply in Venezuela (1.86 DID, +282%). The increase in macrolide, lincosaminde, and streptogramin use was greatest in Peru (0.76 DID, +82.1%), followed by Brazil, Argentina, and Chile.
    [Show full text]
  • Guidelines on Urological Infections
    Guidelines on Urological Infections M. Grabe (Chairman), T.E. Bjerklund-Johansen, H. Botto, M. Çek, K.G. Naber, P. Tenke, F. Wagenlehner © European Association of Urology 2010 TABLE OF CONTENTS PAGE 1. INTRODUCTION 7 1.1 Pathogenesis of urinary tract infections 7 1.2 Microbiological and other laboratory findings 7 1.3 Classification of urological infections 8 1.4 Aim of guidelines 8 1.5 Methods 9 1.6 Level of evidence and grade of guideline recommendations 9 1.7 References 9 2. UNCOMPLICATED URINARY TRACT INFECTIONS IN ADULTS 11 2.1 Definition 11 2.1.1 Aetiological spectrum 11 2.2 Acute uncomplicated cystitis in premenopausal, non-pregnant women 11 2.2.1 Diagnosis 11 2.2.1.1 Clinical diagnosis 11 2.2.1.2 Laboratory diagnosis 11 2.2.2 Therapy 11 2.2.3 Follow up 12 2.3 Acute uncomplicated pyelonephritis in premenopausal, non-pregnant women 12 2.3.1 Diagnosis 12 2.3.1.1 Clinical diagnosis 12 2.3.1.2 Laboratory diagnosis 12 2.3.1.3 Imaging diagnosis 13 2.3.2 Therapy 13 2.3.2.1 Mild and moderate cases of acute uncomplicated pyelonephritis 13 2.3.2.2 Severe cases of acute uncomplicated pyelonephritis 13 2.3.3 Follow-up 14 2.4 Recurrent (uncomplicated) UTIs in women 16 2.4.1 Diagnosis 16 2.4.2 Prevention 16 2.4.2.1 Antimicrobial prophylaxis 16 2.4.2.2 Immunoactive prophylaxis 16 2.4.2.3 Prophylaxis with probiotics 17 2.4.2.4 Prophylaxis with cranberry 17 2.5 Urinary tract infections in pregnancy 17 2.5.1 Definition of significant bacteriuria 17 2.5.2 Screening 17 2.5.3 Treatment of asymptomatic bacteriuria 17 2.5.4 Duration of therapy 18 2.5.5 Follow-up 18 2.5.6 Prophylaxis 18 2.5.7 Treatment of pyelonephritis 18 2.5.8 Complicated UTI 18 2.6 UTIs in postmenopausal women 18 2.6.1 Risk factors 18 2.6.2 Diagnosis 18 2.6.3 Treatment 18 2.7 Acute uncomplicated UTIs in young men 19 2.7.1 Men with acute uncomplicated UTI 19 2.7.2 Men with UTI and concomitant prostate infection 19 2.8 Asymptomatic bacteriuria 19 2.8.1 Diagnosis 19 2.8.2 Screening 19 2.9 References 26 3.
    [Show full text]